nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—SLC22A5—Niacin—atherosclerosis	0.221	0.287	CbGbCtD
Lomefloxacin—ABCC2—Ezetimibe—atherosclerosis	0.146	0.19	CbGbCtD
Lomefloxacin—ABCC2—Simvastatin—atherosclerosis	0.136	0.177	CbGbCtD
Lomefloxacin—ABCC2—Pravastatin—atherosclerosis	0.133	0.173	CbGbCtD
Lomefloxacin—ABCC2—Lovastatin—atherosclerosis	0.133	0.173	CbGbCtD
Lomefloxacin—ABCC2—Irinotecan Pathway—NPC1—atherosclerosis	0.00448	0.165	CbGpPWpGaD
Lomefloxacin—TOP2A—Fluvastatin—Rosuvastatin—atherosclerosis	0.00179	0.343	CbGdCrCtD
Lomefloxacin—TOP2A—Simvastatin—Lovastatin—atherosclerosis	0.00171	0.328	CbGdCrCtD
Lomefloxacin—TOP2A—Simvastatin—Pravastatin—atherosclerosis	0.00171	0.328	CbGdCrCtD
Lomefloxacin—ABCC2—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00144	0.0531	CbGpPWpGaD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.00115	0.0424	CbGpPWpGaD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.0011	0.0406	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000914	0.0336	CbGpPWpGaD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000873	0.0321	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000829	0.0305	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000717	0.0264	CbGpPWpGaD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.000685	0.0252	CbGpPWpGaD
Lomefloxacin—Flushing—Simvastatin—atherosclerosis	0.000572	0.00291	CcSEcCtD
Lomefloxacin—Rhinitis—Niacin—atherosclerosis	0.000568	0.00288	CcSEcCtD
Lomefloxacin—Hepatitis—Niacin—atherosclerosis	0.000566	0.00288	CcSEcCtD
Lomefloxacin—Flatulence—Lovastatin—atherosclerosis	0.000565	0.00287	CcSEcCtD
Lomefloxacin—Dysgeusia—Lovastatin—atherosclerosis	0.000562	0.00285	CcSEcCtD
Lomefloxacin—Rhinitis—Pravastatin—atherosclerosis	0.000559	0.00284	CcSEcCtD
Lomefloxacin—Hepatitis—Pravastatin—atherosclerosis	0.000557	0.00283	CcSEcCtD
Lomefloxacin—Confusional state—Rosuvastatin—atherosclerosis	0.000557	0.00283	CcSEcCtD
Lomefloxacin—Back pain—Lovastatin—atherosclerosis	0.000555	0.00282	CcSEcCtD
Lomefloxacin—Flatulence—Ezetimibe—atherosclerosis	0.000555	0.00282	CcSEcCtD
Lomefloxacin—Pharyngitis—Pravastatin—atherosclerosis	0.000553	0.00281	CcSEcCtD
Lomefloxacin—Chills—Simvastatin—atherosclerosis	0.000553	0.00281	CcSEcCtD
Lomefloxacin—Muscle spasms—Lovastatin—atherosclerosis	0.000552	0.0028	CcSEcCtD
Lomefloxacin—Visual impairment—Niacin—atherosclerosis	0.000546	0.00277	CcSEcCtD
Lomefloxacin—Back pain—Ezetimibe—atherosclerosis	0.000544	0.00277	CcSEcCtD
Lomefloxacin—Muscle spasms—Ezetimibe—atherosclerosis	0.000541	0.00275	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000541	0.00275	CcSEcCtD
Lomefloxacin—Tremor—Lovastatin—atherosclerosis	0.000538	0.00273	CcSEcCtD
Lomefloxacin—Visual impairment—Pravastatin—atherosclerosis	0.000537	0.00273	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000532	0.0027	CcSEcCtD
Lomefloxacin—Flatulence—Simvastatin—atherosclerosis	0.000529	0.00269	CcSEcCtD
Lomefloxacin—Tinnitus—Niacin—atherosclerosis	0.000528	0.00268	CcSEcCtD
Lomefloxacin—Erythema multiforme—Pravastatin—atherosclerosis	0.000527	0.00268	CcSEcCtD
Lomefloxacin—Dysgeusia—Simvastatin—atherosclerosis	0.000526	0.00267	CcSEcCtD
Lomefloxacin—Flushing—Niacin—atherosclerosis	0.000525	0.00267	CcSEcCtD
Lomefloxacin—Angioedema—Lovastatin—atherosclerosis	0.000524	0.00266	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000522	0.00265	CcSEcCtD
Lomefloxacin—Anaemia—Ezetimibe—atherosclerosis	0.00052	0.00264	CcSEcCtD
Lomefloxacin—Tinnitus—Pravastatin—atherosclerosis	0.00052	0.00264	CcSEcCtD
Lomefloxacin—Malaise—Lovastatin—atherosclerosis	0.000517	0.00263	CcSEcCtD
Lomefloxacin—Flushing—Pravastatin—atherosclerosis	0.000517	0.00263	CcSEcCtD
Lomefloxacin—Muscle spasms—Simvastatin—atherosclerosis	0.000516	0.00262	CcSEcCtD
Lomefloxacin—Vertigo—Lovastatin—atherosclerosis	0.000516	0.00262	CcSEcCtD
Lomefloxacin—Angioedema—Ezetimibe—atherosclerosis	0.000514	0.00261	CcSEcCtD
Lomefloxacin—Leukopenia—Lovastatin—atherosclerosis	0.000514	0.00261	CcSEcCtD
Lomefloxacin—Chills—Niacin—atherosclerosis	0.000508	0.00258	CcSEcCtD
Lomefloxacin—Malaise—Ezetimibe—atherosclerosis	0.000508	0.00258	CcSEcCtD
Lomefloxacin—Arrhythmia—Niacin—atherosclerosis	0.000506	0.00257	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000503	0.00256	CcSEcCtD
Lomefloxacin—Tremor—Simvastatin—atherosclerosis	0.000503	0.00255	CcSEcCtD
Lomefloxacin—Chills—Pravastatin—atherosclerosis	0.0005	0.00254	CcSEcCtD
Lomefloxacin—Insomnia—Rosuvastatin—atherosclerosis	0.0005	0.00254	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000498	0.00253	CcSEcCtD
Lomefloxacin—Arrhythmia—Pravastatin—atherosclerosis	0.000498	0.00253	CcSEcCtD
Lomefloxacin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000496	0.00252	CcSEcCtD
Lomefloxacin—Anaemia—Simvastatin—atherosclerosis	0.000496	0.00252	CcSEcCtD
Lomefloxacin—Cough—Ezetimibe—atherosclerosis	0.000491	0.00249	CcSEcCtD
Lomefloxacin—Angioedema—Simvastatin—atherosclerosis	0.00049	0.00249	CcSEcCtD
Lomefloxacin—Myalgia—Lovastatin—atherosclerosis	0.000489	0.00248	CcSEcCtD
Lomefloxacin—Arthralgia—Lovastatin—atherosclerosis	0.000489	0.00248	CcSEcCtD
Lomefloxacin—Chest pain—Lovastatin—atherosclerosis	0.000489	0.00248	CcSEcCtD
Lomefloxacin—Anxiety—Lovastatin—atherosclerosis	0.000487	0.00247	CcSEcCtD
Lomefloxacin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000486	0.00247	CcSEcCtD
Lomefloxacin—Hypertension—Ezetimibe—atherosclerosis	0.000486	0.00247	CcSEcCtD
Lomefloxacin—Flatulence—Niacin—atherosclerosis	0.000486	0.00247	CcSEcCtD
Lomefloxacin—Malaise—Simvastatin—atherosclerosis	0.000484	0.00246	CcSEcCtD
Lomefloxacin—Tension—Niacin—atherosclerosis	0.000484	0.00246	CcSEcCtD
Lomefloxacin—Discomfort—Lovastatin—atherosclerosis	0.000483	0.00245	CcSEcCtD
Lomefloxacin—Vertigo—Simvastatin—atherosclerosis	0.000482	0.00245	CcSEcCtD
Lomefloxacin—Leukopenia—Simvastatin—atherosclerosis	0.00048	0.00244	CcSEcCtD
Lomefloxacin—Myalgia—Ezetimibe—atherosclerosis	0.000479	0.00243	CcSEcCtD
Lomefloxacin—Arthralgia—Ezetimibe—atherosclerosis	0.000479	0.00243	CcSEcCtD
Lomefloxacin—Chest pain—Ezetimibe—atherosclerosis	0.000479	0.00243	CcSEcCtD
Lomefloxacin—Nervousness—Niacin—atherosclerosis	0.000479	0.00243	CcSEcCtD
Lomefloxacin—Flatulence—Pravastatin—atherosclerosis	0.000478	0.00243	CcSEcCtD
Lomefloxacin—Dry mouth—Lovastatin—atherosclerosis	0.000478	0.00243	CcSEcCtD
Lomefloxacin—Tension—Pravastatin—atherosclerosis	0.000476	0.00242	CcSEcCtD
Lomefloxacin—Dysgeusia—Pravastatin—atherosclerosis	0.000475	0.00241	CcSEcCtD
Lomefloxacin—Muscle spasms—Niacin—atherosclerosis	0.000474	0.00241	CcSEcCtD
Lomefloxacin—Discomfort—Ezetimibe—atherosclerosis	0.000473	0.0024	CcSEcCtD
Lomefloxacin—Constipation—Rosuvastatin—atherosclerosis	0.000473	0.0024	CcSEcCtD
Lomefloxacin—Confusional state—Lovastatin—atherosclerosis	0.000472	0.0024	CcSEcCtD
Lomefloxacin—Nervousness—Pravastatin—atherosclerosis	0.000471	0.00239	CcSEcCtD
Lomefloxacin—Dry mouth—Ezetimibe—atherosclerosis	0.000469	0.00238	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000468	0.00238	CcSEcCtD
Lomefloxacin—Muscle spasms—Pravastatin—atherosclerosis	0.000467	0.00237	CcSEcCtD
Lomefloxacin—Confusional state—Ezetimibe—atherosclerosis	0.000463	0.00235	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000459	0.00233	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000459	0.00233	CcSEcCtD
Lomefloxacin—Myalgia—Simvastatin—atherosclerosis	0.000457	0.00232	CcSEcCtD
Lomefloxacin—Chest pain—Simvastatin—atherosclerosis	0.000457	0.00232	CcSEcCtD
Lomefloxacin—Arthralgia—Simvastatin—atherosclerosis	0.000457	0.00232	CcSEcCtD
Lomefloxacin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000455	0.00231	CcSEcCtD
Lomefloxacin—Anxiety—Simvastatin—atherosclerosis	0.000455	0.00231	CcSEcCtD
Lomefloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000455	0.0167	CbGpPWpGaD
Lomefloxacin—Tremor—Pravastatin—atherosclerosis	0.000455	0.00231	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000452	0.0023	CcSEcCtD
Lomefloxacin—Discomfort—Simvastatin—atherosclerosis	0.000451	0.00229	CcSEcCtD
Lomefloxacin—Angioedema—Niacin—atherosclerosis	0.00045	0.00229	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00045	0.00229	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00045	0.00228	CcSEcCtD
Lomefloxacin—Anaemia—Pravastatin—atherosclerosis	0.000448	0.00228	CcSEcCtD
Lomefloxacin—Anorexia—Lovastatin—atherosclerosis	0.000446	0.00227	CcSEcCtD
Lomefloxacin—Skin disorder—Ezetimibe—atherosclerosis	0.000446	0.00227	CcSEcCtD
Lomefloxacin—Angioedema—Pravastatin—atherosclerosis	0.000443	0.00225	CcSEcCtD
Lomefloxacin—Vertigo—Niacin—atherosclerosis	0.000443	0.00225	CcSEcCtD
Lomefloxacin—Syncope—Niacin—atherosclerosis	0.000442	0.00224	CcSEcCtD
Lomefloxacin—Confusional state—Simvastatin—atherosclerosis	0.000442	0.00224	CcSEcCtD
Lomefloxacin—Leukopenia—Niacin—atherosclerosis	0.000441	0.00224	CcSEcCtD
Lomefloxacin—Urticaria—Rosuvastatin—atherosclerosis	0.000439	0.00223	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000438	0.00222	CcSEcCtD
Lomefloxacin—Oedema—Simvastatin—atherosclerosis	0.000438	0.00222	CcSEcCtD
Lomefloxacin—Malaise—Pravastatin—atherosclerosis	0.000438	0.00222	CcSEcCtD
Lomefloxacin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000437	0.00222	CcSEcCtD
Lomefloxacin—Vertigo—Pravastatin—atherosclerosis	0.000436	0.00221	CcSEcCtD
Lomefloxacin—Leukopenia—Pravastatin—atherosclerosis	0.000434	0.00221	CcSEcCtD
Lomefloxacin—Loss of consciousness—Niacin—atherosclerosis	0.000433	0.0022	CcSEcCtD
Lomefloxacin—Cough—Niacin—atherosclerosis	0.00043	0.00218	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000429	0.00218	CcSEcCtD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000428	0.0157	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000427	0.00217	CcSEcCtD
Lomefloxacin—Insomnia—Lovastatin—atherosclerosis	0.000424	0.00215	CcSEcCtD
Lomefloxacin—Cough—Pravastatin—atherosclerosis	0.000423	0.00215	CcSEcCtD
Lomefloxacin—Paraesthesia—Lovastatin—atherosclerosis	0.000421	0.00214	CcSEcCtD
Lomefloxacin—Arthralgia—Niacin—atherosclerosis	0.00042	0.00213	CcSEcCtD
Lomefloxacin—Myalgia—Niacin—atherosclerosis	0.00042	0.00213	CcSEcCtD
Lomefloxacin—Hypertension—Pravastatin—atherosclerosis	0.000419	0.00213	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000418	0.00213	CcSEcCtD
Lomefloxacin—Anorexia—Simvastatin—atherosclerosis	0.000418	0.00212	CcSEcCtD
Lomefloxacin—Dyspnoea—Lovastatin—atherosclerosis	0.000418	0.00212	CcSEcCtD
Lomefloxacin—Insomnia—Ezetimibe—atherosclerosis	0.000415	0.00211	CcSEcCtD
Lomefloxacin—Chest pain—Pravastatin—atherosclerosis	0.000413	0.0021	CcSEcCtD
Lomefloxacin—Arthralgia—Pravastatin—atherosclerosis	0.000413	0.0021	CcSEcCtD
Lomefloxacin—Myalgia—Pravastatin—atherosclerosis	0.000413	0.0021	CcSEcCtD
Lomefloxacin—Paraesthesia—Ezetimibe—atherosclerosis	0.000412	0.00209	CcSEcCtD
Lomefloxacin—Dyspepsia—Lovastatin—atherosclerosis	0.000412	0.00209	CcSEcCtD
Lomefloxacin—Anxiety—Pravastatin—atherosclerosis	0.000412	0.00209	CcSEcCtD
Lomefloxacin—Dry mouth—Niacin—atherosclerosis	0.00041	0.00208	CcSEcCtD
Lomefloxacin—Dyspnoea—Ezetimibe—atherosclerosis	0.00041	0.00208	CcSEcCtD
Lomefloxacin—Discomfort—Pravastatin—atherosclerosis	0.000408	0.00207	CcSEcCtD
Lomefloxacin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000407	0.00207	CcSEcCtD
Lomefloxacin—Decreased appetite—Lovastatin—atherosclerosis	0.000407	0.00207	CcSEcCtD
Lomefloxacin—Dyspepsia—Ezetimibe—atherosclerosis	0.000404	0.00205	CcSEcCtD
Lomefloxacin—Fatigue—Lovastatin—atherosclerosis	0.000404	0.00205	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Niacin—atherosclerosis	0.000402	0.00204	CcSEcCtD
Lomefloxacin—Oedema—Niacin—atherosclerosis	0.000402	0.00204	CcSEcCtD
Lomefloxacin—Constipation—Lovastatin—atherosclerosis	0.0004	0.00203	CcSEcCtD
Lomefloxacin—Confusional state—Pravastatin—atherosclerosis	0.000399	0.00203	CcSEcCtD
Lomefloxacin—Decreased appetite—Ezetimibe—atherosclerosis	0.000399	0.00203	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000399	0.00203	CcSEcCtD
Lomefloxacin—Asthenia—Rosuvastatin—atherosclerosis	0.000396	0.00201	CcSEcCtD
Lomefloxacin—Insomnia—Simvastatin—atherosclerosis	0.000396	0.00201	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000396	0.00201	CcSEcCtD
Lomefloxacin—Oedema—Pravastatin—atherosclerosis	0.000396	0.00201	CcSEcCtD
Lomefloxacin—Fatigue—Ezetimibe—atherosclerosis	0.000396	0.00201	CcSEcCtD
Lomefloxacin—Shock—Niacin—atherosclerosis	0.000396	0.00201	CcSEcCtD
Lomefloxacin—Paraesthesia—Simvastatin—atherosclerosis	0.000393	0.002	CcSEcCtD
Lomefloxacin—Constipation—Ezetimibe—atherosclerosis	0.000393	0.002	CcSEcCtD
Lomefloxacin—Tachycardia—Niacin—atherosclerosis	0.000393	0.00199	CcSEcCtD
Lomefloxacin—Pruritus—Rosuvastatin—atherosclerosis	0.000391	0.00199	CcSEcCtD
Lomefloxacin—Skin disorder—Niacin—atherosclerosis	0.000391	0.00198	CcSEcCtD
Lomefloxacin—Dyspnoea—Simvastatin—atherosclerosis	0.000391	0.00198	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Niacin—atherosclerosis	0.000389	0.00197	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000388	0.00197	CcSEcCtD
Lomefloxacin—Feeling abnormal—Lovastatin—atherosclerosis	0.000386	0.00196	CcSEcCtD
Lomefloxacin—Dyspepsia—Simvastatin—atherosclerosis	0.000386	0.00196	CcSEcCtD
Lomefloxacin—Anorexia—Niacin—atherosclerosis	0.000383	0.00195	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000383	0.00195	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000383	0.00194	CcSEcCtD
Lomefloxacin—Decreased appetite—Simvastatin—atherosclerosis	0.000381	0.00193	CcSEcCtD
Lomefloxacin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000379	0.00192	CcSEcCtD
Lomefloxacin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000378	0.00192	CcSEcCtD
Lomefloxacin—Fatigue—Simvastatin—atherosclerosis	0.000378	0.00192	CcSEcCtD
Lomefloxacin—Anorexia—Pravastatin—atherosclerosis	0.000377	0.00192	CcSEcCtD
Lomefloxacin—Hypotension—Niacin—atherosclerosis	0.000376	0.00191	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000376	0.00191	CcSEcCtD
Lomefloxacin—Constipation—Simvastatin—atherosclerosis	0.000375	0.0019	CcSEcCtD
Lomefloxacin—Urticaria—Lovastatin—atherosclerosis	0.000372	0.00189	CcSEcCtD
Lomefloxacin—Abdominal pain—Lovastatin—atherosclerosis	0.00037	0.00188	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000366	0.00186	CcSEcCtD
Lomefloxacin—Dizziness—Rosuvastatin—atherosclerosis	0.000365	0.00186	CcSEcCtD
Lomefloxacin—Urticaria—Ezetimibe—atherosclerosis	0.000365	0.00185	CcSEcCtD
Lomefloxacin—Insomnia—Niacin—atherosclerosis	0.000364	0.00185	CcSEcCtD
Lomefloxacin—Abdominal pain—Ezetimibe—atherosclerosis	0.000363	0.00184	CcSEcCtD
Lomefloxacin—Paraesthesia—Niacin—atherosclerosis	0.000361	0.00183	CcSEcCtD
Lomefloxacin—Feeling abnormal—Simvastatin—atherosclerosis	0.000361	0.00183	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000361	0.00183	CcSEcCtD
Lomefloxacin—Dyspnoea—Niacin—atherosclerosis	0.000359	0.00182	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000358	0.00182	CcSEcCtD
Lomefloxacin—Insomnia—Pravastatin—atherosclerosis	0.000358	0.00182	CcSEcCtD
Lomefloxacin—Somnolence—Niacin—atherosclerosis	0.000358	0.00182	CcSEcCtD
Lomefloxacin—Paraesthesia—Pravastatin—atherosclerosis	0.000356	0.00181	CcSEcCtD
Lomefloxacin—Dyspepsia—Niacin—atherosclerosis	0.000354	0.0018	CcSEcCtD
Lomefloxacin—Dyspnoea—Pravastatin—atherosclerosis	0.000353	0.00179	CcSEcCtD
Lomefloxacin—Decreased appetite—Niacin—atherosclerosis	0.00035	0.00178	CcSEcCtD
Lomefloxacin—Dyspepsia—Pravastatin—atherosclerosis	0.000349	0.00177	CcSEcCtD
Lomefloxacin—Rash—Rosuvastatin—atherosclerosis	0.000348	0.00177	CcSEcCtD
Lomefloxacin—Dermatitis—Rosuvastatin—atherosclerosis	0.000348	0.00177	CcSEcCtD
Lomefloxacin—Urticaria—Simvastatin—atherosclerosis	0.000348	0.00177	CcSEcCtD
Lomefloxacin—Abdominal pain—Simvastatin—atherosclerosis	0.000346	0.00176	CcSEcCtD
Lomefloxacin—Headache—Rosuvastatin—atherosclerosis	0.000346	0.00176	CcSEcCtD
Lomefloxacin—Hypersensitivity—Lovastatin—atherosclerosis	0.000345	0.00175	CcSEcCtD
Lomefloxacin—Decreased appetite—Pravastatin—atherosclerosis	0.000344	0.00175	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000343	0.0126	CbGpPWpGaD
Lomefloxacin—Fatigue—Pravastatin—atherosclerosis	0.000341	0.00173	CcSEcCtD
Lomefloxacin—Constipation—Pravastatin—atherosclerosis	0.000339	0.00172	CcSEcCtD
Lomefloxacin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000338	0.00172	CcSEcCtD
Lomefloxacin—Asthenia—Lovastatin—atherosclerosis	0.000336	0.00171	CcSEcCtD
Lomefloxacin—Pruritus—Lovastatin—atherosclerosis	0.000331	0.00168	CcSEcCtD
Lomefloxacin—Asthenia—Ezetimibe—atherosclerosis	0.00033	0.00167	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Niacin—atherosclerosis	0.000329	0.00167	CcSEcCtD
Lomefloxacin—Nausea—Rosuvastatin—atherosclerosis	0.000328	0.00167	CcSEcCtD
Lomefloxacin—Feeling abnormal—Pravastatin—atherosclerosis	0.000326	0.00166	CcSEcCtD
Lomefloxacin—Pruritus—Ezetimibe—atherosclerosis	0.000325	0.00165	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000324	0.00164	CcSEcCtD
Lomefloxacin—Hypersensitivity—Simvastatin—atherosclerosis	0.000323	0.00164	CcSEcCtD
Lomefloxacin—Diarrhoea—Lovastatin—atherosclerosis	0.00032	0.00163	CcSEcCtD
Lomefloxacin—Urticaria—Niacin—atherosclerosis	0.00032	0.00162	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.000319	0.0117	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Niacin—atherosclerosis	0.000318	0.00161	CcSEcCtD
Lomefloxacin—Urticaria—Pravastatin—atherosclerosis	0.000315	0.0016	CcSEcCtD
Lomefloxacin—Asthenia—Simvastatin—atherosclerosis	0.000314	0.0016	CcSEcCtD
Lomefloxacin—Diarrhoea—Ezetimibe—atherosclerosis	0.000314	0.0016	CcSEcCtD
Lomefloxacin—Abdominal pain—Pravastatin—atherosclerosis	0.000313	0.00159	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000311	0.0114	CbGpPWpGaD
Lomefloxacin—Pruritus—Simvastatin—atherosclerosis	0.00031	0.00157	CcSEcCtD
Lomefloxacin—Dizziness—Lovastatin—atherosclerosis	0.00031	0.00157	CcSEcCtD
Lomefloxacin—Dizziness—Ezetimibe—atherosclerosis	0.000304	0.00154	CcSEcCtD
Lomefloxacin—Diarrhoea—Simvastatin—atherosclerosis	0.0003	0.00152	CcSEcCtD
Lomefloxacin—Vomiting—Lovastatin—atherosclerosis	0.000298	0.00151	CcSEcCtD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000297	0.0109	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Niacin—atherosclerosis	0.000296	0.00151	CcSEcCtD
Lomefloxacin—Rash—Lovastatin—atherosclerosis	0.000295	0.0015	CcSEcCtD
Lomefloxacin—Dermatitis—Lovastatin—atherosclerosis	0.000295	0.0015	CcSEcCtD
Lomefloxacin—Headache—Lovastatin—atherosclerosis	0.000293	0.00149	CcSEcCtD
Lomefloxacin—Vomiting—Ezetimibe—atherosclerosis	0.000292	0.00148	CcSEcCtD
Lomefloxacin—Hypersensitivity—Pravastatin—atherosclerosis	0.000292	0.00148	CcSEcCtD
Lomefloxacin—Dizziness—Simvastatin—atherosclerosis	0.00029	0.00147	CcSEcCtD
Lomefloxacin—Rash—Ezetimibe—atherosclerosis	0.00029	0.00147	CcSEcCtD
Lomefloxacin—Dermatitis—Ezetimibe—atherosclerosis	0.000289	0.00147	CcSEcCtD
Lomefloxacin—Asthenia—Niacin—atherosclerosis	0.000289	0.00147	CcSEcCtD
Lomefloxacin—Headache—Ezetimibe—atherosclerosis	0.000288	0.00146	CcSEcCtD
Lomefloxacin—Pruritus—Niacin—atherosclerosis	0.000285	0.00145	CcSEcCtD
Lomefloxacin—Asthenia—Pravastatin—atherosclerosis	0.000284	0.00144	CcSEcCtD
Lomefloxacin—Pruritus—Pravastatin—atherosclerosis	0.00028	0.00142	CcSEcCtD
Lomefloxacin—Vomiting—Simvastatin—atherosclerosis	0.000279	0.00141	CcSEcCtD
Lomefloxacin—Nausea—Lovastatin—atherosclerosis	0.000278	0.00141	CcSEcCtD
Lomefloxacin—Rash—Simvastatin—atherosclerosis	0.000276	0.0014	CcSEcCtD
Lomefloxacin—Dermatitis—Simvastatin—atherosclerosis	0.000276	0.0014	CcSEcCtD
Lomefloxacin—Diarrhoea—Niacin—atherosclerosis	0.000275	0.0014	CcSEcCtD
Lomefloxacin—Headache—Simvastatin—atherosclerosis	0.000274	0.00139	CcSEcCtD
Lomefloxacin—Nausea—Ezetimibe—atherosclerosis	0.000273	0.00139	CcSEcCtD
Lomefloxacin—Diarrhoea—Pravastatin—atherosclerosis	0.000271	0.00138	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000269	0.0099	CbGpPWpGaD
Lomefloxacin—Dizziness—Niacin—atherosclerosis	0.000266	0.00135	CcSEcCtD
Lomefloxacin—ABCC2—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000266	0.00978	CbGpPWpGaD
Lomefloxacin—Dizziness—Pravastatin—atherosclerosis	0.000262	0.00133	CcSEcCtD
Lomefloxacin—Nausea—Simvastatin—atherosclerosis	0.00026	0.00132	CcSEcCtD
Lomefloxacin—Vomiting—Niacin—atherosclerosis	0.000256	0.0013	CcSEcCtD
Lomefloxacin—Rash—Niacin—atherosclerosis	0.000254	0.00129	CcSEcCtD
Lomefloxacin—Dermatitis—Niacin—atherosclerosis	0.000253	0.00129	CcSEcCtD
Lomefloxacin—Headache—Niacin—atherosclerosis	0.000252	0.00128	CcSEcCtD
Lomefloxacin—Vomiting—Pravastatin—atherosclerosis	0.000252	0.00128	CcSEcCtD
Lomefloxacin—Rash—Pravastatin—atherosclerosis	0.00025	0.00127	CcSEcCtD
Lomefloxacin—Dermatitis—Pravastatin—atherosclerosis	0.000249	0.00127	CcSEcCtD
Lomefloxacin—Headache—Pravastatin—atherosclerosis	0.000248	0.00126	CcSEcCtD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000245	0.00902	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—PPARA—atherosclerosis	0.00024	0.00884	CbGpPWpGaD
Lomefloxacin—Nausea—Niacin—atherosclerosis	0.000239	0.00121	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—UTS2—atherosclerosis	0.000239	0.00878	CbGpPWpGaD
Lomefloxacin—Nausea—Pravastatin—atherosclerosis	0.000235	0.00119	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—AHR—atherosclerosis	0.000218	0.00803	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—ESR1—atherosclerosis	0.000218	0.00801	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen metabolism—GSTM1—atherosclerosis	0.000214	0.00786	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00021	0.00772	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CST3—atherosclerosis	0.000202	0.00741	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.0002	0.00736	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.0002	0.00736	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000197	0.00726	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000195	0.00717	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NAMPT—atherosclerosis	0.000191	0.00702	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.000187	0.00687	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—AHR—atherosclerosis	0.000187	0.00687	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000183	0.00671	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—F7—atherosclerosis	0.000181	0.00665	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.00018	0.00663	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.00017	0.00626	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000165	0.00606	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—GHRL—atherosclerosis	0.000161	0.00593	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000161	0.00591	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00016	0.00589	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000159	0.00585	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000158	0.00581	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—atherosclerosis	0.000156	0.00574	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000148	0.00544	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—atherosclerosis	0.000148	0.00543	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000128	0.00471	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000125	0.00459	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SIRT1—atherosclerosis	0.000123	0.00452	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—atherosclerosis	0.000122	0.00448	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00012	0.00443	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—APOE—atherosclerosis	0.00012	0.00441	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000115	0.00425	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—HMOX1—atherosclerosis	0.000114	0.00421	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000114	0.0042	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000113	0.00416	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PRKCG—atherosclerosis	0.000113	0.00414	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000111	0.0041	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTM1—atherosclerosis	0.000107	0.00392	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—AGER—atherosclerosis	0.000103	0.00378	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARA—atherosclerosis	0.000102	0.00376	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000102	0.00374	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	9.9e-05	0.00364	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG5—atherosclerosis	9.79e-05	0.0036	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—LEP—atherosclerosis	9.7e-05	0.00357	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	9.65e-05	0.00355	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	9.41e-05	0.00346	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	9.2e-05	0.00339	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—PDGFB—atherosclerosis	9.17e-05	0.00337	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	9.13e-05	0.00336	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NOS2—atherosclerosis	9.04e-05	0.00333	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—GPX1—atherosclerosis	9.03e-05	0.00332	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP7A1—atherosclerosis	8.5e-05	0.00313	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARG—atherosclerosis	8.45e-05	0.00311	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP7A1—atherosclerosis	8.39e-05	0.00308	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	8.35e-05	0.00307	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	8.27e-05	0.00304	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	7.92e-05	0.00291	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP27A1—atherosclerosis	7.86e-05	0.00289	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP27A1—atherosclerosis	7.75e-05	0.00285	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SERPINE1—atherosclerosis	7.61e-05	0.0028	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.44e-05	0.00274	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CETP—atherosclerosis	7.25e-05	0.00267	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	7.16e-05	0.00263	CbGpPWpGaD
Lomefloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	7.14e-05	0.00262	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	6.92e-05	0.00255	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.39e-05	0.00235	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	6.01e-05	0.00221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	6e-05	0.00221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	5.93e-05	0.00218	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—atherosclerosis	5.92e-05	0.00218	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.91e-05	0.00217	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	5.69e-05	0.00209	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—MAPK8—atherosclerosis	5.67e-05	0.00209	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	5.59e-05	0.00206	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	5.45e-05	0.00201	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PLG—atherosclerosis	5.43e-05	0.002	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	5.32e-05	0.00196	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CETP—atherosclerosis	5.3e-05	0.00195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	5.29e-05	0.00195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	5.26e-05	0.00193	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	5.16e-05	0.0019	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.01e-05	0.00184	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	5.01e-05	0.00184	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	4.93e-05	0.00181	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOB—atherosclerosis	4.8e-05	0.00177	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.68e-05	0.00172	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.67e-05	0.00172	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	4.56e-05	0.00168	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	4.56e-05	0.00168	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	4.48e-05	0.00165	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—TGFB1—atherosclerosis	4.35e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	4.11e-05	0.00151	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.05e-05	0.00149	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PLG—atherosclerosis	3.97e-05	0.00146	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	3.84e-05	0.00141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	3.84e-05	0.00141	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.8e-05	0.0014	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.67e-05	0.00135	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—atherosclerosis	3.62e-05	0.00133	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	3.6e-05	0.00132	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.51e-05	0.00129	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	3.51e-05	0.00129	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.48e-05	0.00128	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	3.46e-05	0.00127	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	3.39e-05	0.00125	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	3.39e-05	0.00125	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	3.32e-05	0.00122	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	3.27e-05	0.0012	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.02e-05	0.00111	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—atherosclerosis	3.01e-05	0.00111	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.96e-05	0.00109	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	2.86e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	2.86e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	2.86e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	2.86e-05	0.00105	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	2.83e-05	0.00104	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.78e-05	0.00102	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	2.73e-05	0.001	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.62e-05	0.000963	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.52e-05	0.000927	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—atherosclerosis	2.5e-05	0.000919	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	2.49e-05	0.000916	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.43e-05	0.000895	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLTP—atherosclerosis	2.34e-05	0.000861	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—atherosclerosis	2.23e-05	0.000821	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.2e-05	0.000809	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.17e-05	0.000798	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.16e-05	0.000793	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.14e-05	0.000788	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.09e-05	0.00077	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.03e-05	0.000746	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.03e-05	0.000746	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2e-05	0.000737	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.89e-05	0.000696	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.69e-05	0.00062	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.6e-05	0.00059	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FABP4—atherosclerosis	1.51e-05	0.000555	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LCAT—atherosclerosis	1.51e-05	0.000555	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA4—atherosclerosis	1.48e-05	0.000544	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.45e-05	0.000535	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.39e-05	0.00051	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.34e-05	0.000494	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.32e-05	0.000487	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.29e-05	0.000475	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.27e-05	0.000469	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.27e-05	0.000469	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA2—atherosclerosis	1.27e-05	0.000469	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.27e-05	0.000469	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.26e-05	0.000463	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.26e-05	0.000462	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LPA—atherosclerosis	1.22e-05	0.000447	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BGN—atherosclerosis	1.18e-05	0.000433	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.17e-05	0.00043	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA5—atherosclerosis	1.17e-05	0.000429	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.13e-05	0.000416	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.12e-05	0.000413	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.11e-05	0.000408	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.1e-05	0.000404	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.1e-05	0.000403	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.08e-05	0.000399	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1e-05	0.000368	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NAMPT—atherosclerosis	9.72e-06	0.000357	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.66e-06	0.000355	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LIPC—atherosclerosis	9.66e-06	0.000355	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOC3—atherosclerosis	9.6e-06	0.000353	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LDLR—atherosclerosis	9.54e-06	0.000351	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CETP—atherosclerosis	9.32e-06	0.000343	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SCARB1—atherosclerosis	8.92e-06	0.000328	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.69e-06	0.00032	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.43e-06	0.00031	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.6e-06	0.00028	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.51e-06	0.000276	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.44e-06	0.000237	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOB—atherosclerosis	6.17e-06	0.000227	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—atherosclerosis	6e-06	0.000221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—LPL—atherosclerosis	5.89e-06	0.000217	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GPX1—atherosclerosis	5.75e-06	0.000211	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CD36—atherosclerosis	5.6e-06	0.000206	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.31e-06	0.000195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARA—atherosclerosis	5.21e-06	0.000191	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AGT—atherosclerosis	5.04e-06	0.000185	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOE—atherosclerosis	4.94e-06	0.000182	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAV1—atherosclerosis	4.9e-06	0.00018	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—APOA1—atherosclerosis	4.88e-06	0.00018	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.46e-06	0.000164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARG—atherosclerosis	4.3e-06	0.000158	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—INS—atherosclerosis	4.22e-06	0.000155	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—atherosclerosis	3.87e-06	0.000142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NOS3—atherosclerosis	3.7e-06	0.000136	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.39e-06	0.000124	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—atherosclerosis	1.7e-06	6.26e-05	CbGpPWpGaD
